Shield Therapeutics Plc
(LSE) STX
Shield Therapeutics Plc Financials at a Glance
Market Cap
$10.09B
Revenue (TTM)
$70.05M
Net Income (TTM)
$36.82M
EPS (TTM)
$-1.28
P/E Ratio
-7.38
Dividend
$0.00
Beta (Volatility)
-0.11 (Low)
Dividend
$0.00
Beta (Volatility)
-0.11 (Low)
Price
$9.44
Volume
4,449,557
Open
$8.90
Price
$9.44
Volume
4,449,557
Open
$8.90
Previous Close
$9.44
Daily Range
$8.82 - $9.67
52-Week Range
$2.20 - $12.50
Dividend
$0.00
Beta (Volatility)
-0.11 (Low)
Price
$9.44
Volume
4,449,557
Open
$8.90
Previous Close
$9.44
Daily Range
$8.82 - $9.67
52-Week Range
$2.20 - $12.50
STX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Shield Therapeutics Plc
Industry
Pharmaceuticals
Sector
Health CareEmployees
63
CEO
Karl Anders Lundström
Website
www.shieldtherapeutics.comHeadquarters
Gateshead, NE8 3DF, GB
STX Financials
Key Financial Metrics (TTM)
Gross Margin
44%
Operating Margin
-20%
Net Income Margin
-35%
Return on Equity
0%
Return on Capital
-58%
Return on Assets
-24%
Earnings Yield
-13.55%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$10.09B
Shares Outstanding
1.07B
Volume
4.45M
Short Interest
0.00%
Avg. Volume
2.09M
Financials (TTM)
Gross Profit
$22.38M
Operating Income
$10.30M
EBITDA
$10.30M
Operating Cash Flow
$8.81M
Capital Expenditure
$24.50K
Free Cash Flow
$8.83M
Cash & ST Invst.
$11.63M
Total Debt
$0.00
Shield Therapeutics Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$28.39M
+306.5%
Gross Profit
$12.10M
+1131.9%
Gross Margin
42.63%
N/A
Market Cap
$10.09B
N/A
Market Cap/Employee
$160.09M
N/A
Employees
63
N/A
Net Income
$8.16M
+50.6%
EBITDA
$4.32M
+72.4%
Quarterly Fundamentals
Net Cash
$11.63M
+323.8%
Accounts Receivable
$24.39M
+177.3%
Inventory
$9.22M
+266.9%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-23.78%
N/A
Return on Invested Capital
-58.30%
N/A
Free Cash Flow
$13.02M
+12.3%
Operating Cash Flow
$13.00M
+6.1%